TY  - JOUR
AU  - Cotes Sanchís, Almudena
AU  - Gallego, Javier
AU  - Hernandez, Raquel
AU  - Arrazubi, Virginia
AU  - Custodio, Ana
AU  - Cano, Juana María
AU  - Aguado, Gema
AU  - Macias, Ismael
AU  - Lopez, Carlos
AU  - López, Flora
AU  - Visa, Laura
AU  - Garrido, Marcelo
AU  - Martínez Lago, Nieves
AU  - Fernández Montes, Ana
AU  - Limón, María Luisa
AU  - Azkárate, Aitor
AU  - Pimentel, Paola
AU  - Reguera, Pablo
AU  - Ramchandani, Avinash
AU  - Cacho, Juan Diego
AU  - Martín Carnicero, Alfonso
AU  - Granja, Mónica
AU  - Martín Richard, Marta
AU  - Hernández Pérez, Carolina
AU  - Hurtado, Alicia
AU  - Serra, Olbia
AU  - Buxo, Elvira
AU  - Vidal Tocino, Rosario
AU  - Jimenez-Fonseca, Paula
AU  - Carmona-Bayonas, Alberto
PY  - 2020
DO  - 10.1371/journal.pone.0235848
UR  - http://hdl.handle.net/10668/16030
T2  - PloS one
AB  - Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice. The study population comprised patients with AGC in...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Immunological
KW  - Antineoplastic Agents, Phytogenic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Drug Utilization
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Platinum Compounds
KW  - Registries
KW  - Stomach Neoplasms
KW  - Survival Analysis
TI  - Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
TY  - research article
VL  - 15
ER  -